An introduction to the endocannabinoid system: from the early to the latest concepts.
paper
Cited
Public
Unavailable
- Authors
- De Petrocellis, Luciano; Di Marzo, Vincenzo
- Year
- 2009
- Journal
- Best practice & research. Clinical endocrinology & metabolism
- PMID
- 19285257
- DOI
- 10.1016/j.beem.2008.10.013
A rather complex and pleiotropic endogenous signalling system was discovered in the late 1990s, starting from studies on the mechanism of action of Delta(9)-tetrahydrocannabinol, the major psychoactive principle of the hemp plant Cannabis sativa. This system includes: (1) at least two G-protein-coupled receptors, known as the cannabinoid CB(1) and CB(2) receptors; (2) the endogenous agonists at these receptors, known as endocannabinoids, of which anandamide and 2-arachidonoylglycerol are the best known; and (3) proteins and enzymes for the regulation of endocannabinoid levels and action at receptors. The number of the members of this endocannabinoid signalling system seems to be ever increasing as new non-CB(1) non-CB(2) receptors for endocannabinoids, endocannabinoid-related molecules with little activity at CB(1) and CB(2) receptors, and new enzymes for endocannabinoid biosynthesis and degradation are being identified every year. The complexity of the endocannabinoid system and of its physiological and pathological function is outlined in this introductory chapter, for a better understanding of the subsequent chapters in this special issue.
No figures extracted from this document.
No chunks β full text not yet ingested.
No entities extracted from this document yet.
No uploaded files.
Not in any collection.
No citations found.
In this knowledge base
External
| Title | Authors | Journal | Year | Link |
|---|---|---|---|---|
| From localization to function: comparative analysis of CB1 in sperm across species and its epigenetic role in humans. | LombΓ³ M et al. | β | 2026 | β |
| The endocannabinoid system regulates both ependymoglial and neuronal cell responses to a tail amputation in the axolotl. | Tolentino M et al. | β | 2026 | β |
| Cannabinoids in preclinical research of sepsis: a scoping review. | Inamassu CH et al. | β | 2025 | β |
| Decreased GPR55 expression links B-cell activation and vascular remodelling in atherosclerosis in patients with early rheumatoid arthritis. | Miranda-Prieto D et al. | β | 2025 | β |
| Identification and experimental validation of biomarkers associated with the endocannabinoid system in major depressive disorder. | Wang L et al. | β | 2025 | β |
| Identification of a Possible Endocannabinoid-Mediated Mechanism of Action of Cetylated Fatty Acids. | Bononi G et al. | β | 2025 | β |
| Reframing type 1 diabetes through the endocannabinoidome-microbiota axis: a systems biology perspective. | Εukowski W | β | 2025 | β |
| Role of Cannabis in the Management of Chronic Non-Cancer Pain: A Narrative Review. | Al-Husinat L et al. | β | 2025 | β |
| Streamlined Sample Cleanup: Small Molecule Fractionation and Extraction Via Low-Volume Polymer Monolithic Columns for In-Line Analysis. | Bremer I et al. | β | 2025 | β |
| Aerobic Exercise and Endocannabinoids: A Narrative Review of Stress Regulation and Brain Reward Systems. | Gupta S et al. | β | 2024 | β |
| Local activation of CB1 receptors by synthetic and endogenous cannabinoids dampens burst firing mode of reticular thalamic nucleus neurons in rats under ketamine anesthesia. | Aguirre-RodrΓguez CA et al. | β | 2024 | β |
| Pharmacological blockade of 2-AG degradation ameliorates clinical, neuroinflammatory and synaptic alterations in experimental autoimmune encephalomyelitis. | Guadalupi L et al. | β | 2024 | β |
| Potential Neuroprotective Effect of the Endocannabinoid System on Parkinson's Disease. | Urmeneta-OrtΓz MF et al. | β | 2024 | β |
| Quantal size increase induced by the endocannabinoid 2-arachidonoylglycerol requires activation of CGRP receptors in mouse motor synapses. | Tarasova E et al. | β | 2024 | β |
| The Efficacy of Cannabis in Oncology Patient Care and Its Anti-Tumor Effects. | Shalata W et al. | β | 2024 | β |
| Therapeutic applicability of cannabidiol and other phytocannabinoids in epilepsy, multiple sclerosis and Parkinson's disease and in comorbidity with psychiatric disorders. | de FΓ‘tima Dos Santos Sampaio M et al. | β | 2024 | β |
| TRPV1 channel in the pathophysiology of epilepsy and its potential as a molecular target for the development of new antiseizure drug candidates. | SocaΕa K et al. | β | 2024 | β |
| Cannabidiol in sports: insights on how CBD could improve performance and recovery. | Rojas-Valverde D et al. | β | 2023 | β |
| Cannabinoids as Prospective Anti-Cancer Drugs: Mechanism of Action in Healthy and Cancer Cells. | BoyacΔ±oΔlu Γ et al. | β | 2023 | β |
| Cannabinoids in neuroinflammatory disorders: Focusing on multiple sclerosis, Parkinsons, and Alzheimers diseases. | Abd-Nikfarjam B et al. | β | 2023 | β |
| Cannabis Unveiled: An Exploration of Marijuana's History, Active Compounds, Effects, Benefits, and Risks on Human Health. | Hasan KM | β | 2023 | β |
| Could cannabinoids provide a new hope for ovarian cancer patients? | Kaur R et al. | β | 2023 | β |
| Plasma endocannabinoids and cannabimimetic fatty acid derivatives are altered in cyclic vomiting syndrome: The effects of sham feeding. | Bashashati M et al. | β | 2023 | β |
| Cannabinol: History, Syntheses, and Biological Profile of the Greatest "Minor" Cannabinoid. | Maioli C et al. | β | 2022 | β |
| Clinical Research Evidence Supporting Administration and Dosing Recommendations of Medicinal Cannabis as Analgesic in Cancer Patients. | Christensen C et al. | β | 2022 | β |
| Exploration of Multiverse Activities of Endocannabinoids in Biological Systems. | Behl T et al. | β | 2022 | β |
| <i>Cannabis</i> for Medical Use: Versatile Plant Rather Than a Single Drug. | Procaccia S et al. | β | 2022 | β |
| N-Oleoyl dopamine induces IL-10 via central nervous system TRPV1 and improves endotoxemia and sepsis outcomes. | Joffre J et al. | β | 2022 | β |
| Phytocannabinoids and Cannabis-Based Products as Alternative Pharmacotherapy in Neurodegenerative Diseases: From Hypothesis to Clinical Practice. | Paes-Colli Y et al. | β | 2022 | β |
| Recent Advances in Endocannabinoid System Targeting for Improved Specificity: Strategic Approaches to Targeted Drug Delivery. | Dasram MH et al. | β | 2022 | β |
| Symposium review: Adipose tissue endocrinology in the periparturient period of dairy cows. | HΓ€ussler S et al. | β | 2022 | β |
| Terpene-Enriched CBD oil for treating autism-derived symptoms unresponsive to pure CBD: Case report. | Raz N et al. | β | 2022 | β |
| The endocannabinoid system in zebrafish and its potential to study the effects of Cannabis in humans. | Bailone RL et al. | β | 2022 | β |
| Cannabidiol Does Not Cause Significant Changes to Working Memory Performance in the N-Back Task. | Jones Γ et al. | β | 2021 | β |
| Effects of Cannabinoid Exposure during Neurodevelopment on Future Effects of Drugs of Abuse: A Preclinical Perspective. | Farrelly AM et al. | β | 2021 | β |
| Endocannabinoid System and Tumour Microenvironment: New Intertwined Connections for Anticancer Approaches. | Iozzo M et al. | β | 2021 | β |
| From a Designer Drug to the Discovery of Selective Cannabinoid Type 2 Receptor Agonists with Favorable Pharmacokinetic Profiles for the Treatment of Systemic Sclerosis. | Jiang BE et al. | β | 2021 | β |
| Molecular Mechanism of Cannabinoids in Cancer Progression. | Pagano C et al. | β | 2021 | β |
| Potassium channels as molecular targets of endocannabinoids. | Lin YF | β | 2021 | β |
| Potential Role of Cannabidiol on Sports Recovery: A Narrative Review. | Rojas-Valverde D | β | 2021 | β |
| The Role of Cannabidiol in Neurological Disorders. | Chayasirisobhon S | β | 2021 | β |
| A Critical Review of the Role of the Cannabinoid Compounds Ξ<sup>9</sup>-Tetrahydrocannabinol (Ξ<sup>9</sup>-THC) and Cannabidiol (CBD) and their Combination in Multiple Sclerosis Treatment. | Jones Γ et al. | β | 2020 | β |
| Antidepressant-like effects of URB597 and JZL184 in male and female rats exposed to early life stress. | Alteba S et al. | β | 2020 | β |
| Characterization of the molecular packing, thermotropic phase behaviour and critical micellar concentration of a homologous series of N-acyltaurines (n = 9-18). PXRD, DSC and fluorescence spectroscopic studies. | Arul Prakash S et al. | β | 2020 | β |
| Design and synthesis of fluorescent ligands for the detection of cannabinoid type 2 receptor (CB2R). | Spinelli F et al. | β | 2020 | β |
| Effects of O-1602 and CBD on TNBS-induced colonic disturbances. | Wei D et al. | β | 2020 | β |
| Functionalized Cannabinoid Subtype 2 Receptor Ligands: Fluorescent, PET, Photochromic and Covalent Molecular Probes. | Basagni F et al. | β | 2020 | β |
| Letter to the editor: Are the physiological effects of dietary n-3 fatty acids partly mediated by changes in activity of the endocannabinoid system in dairy cows? | Zachut M | β | 2020 | β |
| Mechanisms of Action and Pharmacokinetics of Cannabis. | Chayasirisobhon S | β | 2020 | β |
| Plant-derived natural therapeutics targeting cannabinoid receptors in metabolic syndrome and its complications: A review. | Patil AS et al. | β | 2020 | β |
| Reciprocal Influences of HIV and Cannabinoids on the Brain and Cognitive Function. | Towe SL et al. | β | 2020 | β |
| Specific shifts in the endocannabinoid system in hibernating brown bears. | Boyer C et al. | β | 2020 | β |
| Synthetic bioactive olivetol-related amides: The influence of the phenolic group in cannabinoid receptor activity. | Brizzi A et al. | β | 2020 | β |
| Activation of cannabinoid 2 receptor relieves colonic hypermotility in a rat model of irritable bowel syndrome. | Lin M et al. | β | 2019 | β |
| Brain activity of anandamide: a rewarding bliss? | Scherma M et al. | β | 2019 | β |
| Cannabis effects on lipoproteins. | Lazarte J et al. | β | 2019 | β |
| Experience during adolescence shapes brain development: From synapses and networks to normal and pathological behavior. | Dow-Edwards D et al. | β | 2019 | β |
| Experimental Cannabinoid 2 Receptor Activation by Phyto-Derived and Synthetic Cannabinoid Ligands in LPS-Induced Interstitial Cystitis in Mice. | Berger G et al. | β | 2019 | β |
| Expression of Cannabinoid Receptors in Myometrium and its Correlation With Dysmenorrhea in Adenomyosis. | Shen X et al. | β | 2019 | β |
| Study protocol for a randomised, double-blind, placebo-controlled study evaluating the Efficacy of cannabis-based Medicine Extract in slowing the disease pRogression of Amyotrophic Lateral sclerosis or motor neurone Disease: the EMERALD trial. | Urbi B et al. | β | 2019 | β |
| An Analysis of Endocannabinoid Concentrations and Mood Following Singing and Exercise in Healthy Volunteers. | Stone NL et al. | β | 2018 | β |
| Medicinal Properties of Cannabinoids, Terpenes, and Flavonoids in Cannabis, and Benefits in Migraine, Headache, and Pain: An Update on Current Evidence and Cannabis Science. | Baron EP | β | 2018 | β |
| Modulation of mean arterial pressure and diuresis by renomedullary infusion of a selective inhibitor of fatty acid amide hydrolase. | Ahmad A et al. | β | 2018 | β |
| Overlaps in pharmacology for the treatment of chronic pain and mental health disorders. | Sutherland AM et al. | β | 2018 | β |
| Patterns of medicinal cannabis use, strain analysis, and substitution effect among patients with migraine, headache, arthritis, and chronic pain in a medicinal cannabis cohort. | Baron EP et al. | β | 2018 | β |
| Role of Nitric Oxide in the Cardiovascular and Renal Systems. | Ahmad A et al. | β | 2018 | β |
| Seasonal Changes in Endocannabinoid Concentrations between Active and Hibernating Marmots (Marmota flaviventris). | Mulawa EA et al. | β | 2018 | β |
| Theoretical Explanation for Reduced Body Mass Index and Obesity Rates in <i>Cannabis</i> Users. | Clark TM et al. | β | 2018 | β |
| Biological evaluation of pyridone alkaloids on the endocannabinoid system. | Chicca A et al. | β | 2017 | β |
| Cannabinoid derivatives exert a potent anti-myeloma activity both in vitro and in vivo. | Barbado MV et al. | β | 2017 | β |
| Endocannabinoid Analytical Methodologies: Techniques That Drive Discoveries That Drive Techniques. | Piscitelli F et al. | β | 2017 | β |
| Interplay Between n-3 and n-6 Long-Chain Polyunsaturated Fatty Acids and the Endocannabinoid System in Brain Protection and Repair. | Dyall SC | β | 2017 | β |
| Review: The Role of Cannabinoids on Esophageal Function-What We Know Thus Far. | Gotfried J et al. | β | 2017 | β |
| Anti-inflammatory effect of cannabinoid agonist WIN55, 212 on mouse experimental colitis is related to inhibition of p38MAPK. | Feng YJ et al. | β | 2016 | β |
| CB2 and GPR55 Receptors as Therapeutic Targets for Systemic Immune Dysregulation. | Zhou J et al. | β | 2016 | β |
| Elevated Systemic Levels of Endocannabinoids and Related Mediators Across the Menstrual Cycle in Women With Endometriosis. | Sanchez AM et al. | β | 2016 | β |
| Endocannabinoid system as a regulator of tumor cell malignancy - biological pathways and clinical significance. | Pyszniak M et al. | β | 2016 | β |
| Evaluation of cannabinoid CB1 and CB2 receptors expression in mobile tongue squamous cell carcinoma: associations with clinicopathological parameters and patients' survival. | Theocharis S et al. | β | 2016 | β |
| Genetic and Environmental Factors Associated with Cannabis Involvement. | Bogdan R et al. | β | 2016 | β |
| Lipidomic Analysis of Endocannabinoid Signaling: Targeted Metabolite Identification and Quantification. | Keereetaweep J et al. | β | 2016 | β |
| Malonylation of Glucosylated N-Lauroylethanolamine: A NEW PATHWAY THAT DETERMINES N-ACYLETHANOLAMINE METABOLIC FATE IN PLANTS. | Khan BR et al. | β | 2016 | β |
| Morphine-induced locomotor sensitization produces structural plasticity in the mesocorticolimbic system dependent on CB1-R activity. | Guegan T et al. | β | 2016 | β |
| Potential therapeutic targets and the role of technology in developing novel cannabinoid drugs from cyanobacteria. | Vijayakumar S et al. | β | 2016 | β |
| Cannabis and adolescent brain development. | Lubman DI et al. | β | 2015 | β |
| Clinical Significance of Cannabinoid Receptors CB1 and CB2 Expression in Human Malignant and Benign Thyroid Lesions. | Lakiotaki E et al. | β | 2015 | β |
| Comprehensive Review of Medicinal Marijuana, Cannabinoids, and Therapeutic Implications in Medicine and Headache: What a Long Strange Trip It's Been β¦. | Baron EP | β | 2015 | β |
| Effects of mood inductions by meal ambiance and moderate alcohol consumption on endocannabinoids and N-acylethanolamines in humans: a randomized crossover trial. | Schrieks IC et al. | β | 2015 | β |
| Endocannabinoids and acute pain after total knee arthroplasty. | Azim S et al. | β | 2015 | β |
| Monoacylglycerol lipase (MGLL) polymorphism rs604300 interacts with childhood adversity to predict cannabis dependence symptoms and amygdala habituation: Evidence from an endocannabinoid system-level analysis. | Carey CE et al. | β | 2015 | β |
| New approaches in the design and development of cannabinoid receptor ligands: multifunctional and bivalent compounds. | Nimczick M et al. | β | 2015 | β |
| Rising stars: modulation of brain functions by astroglial type-1 cannabinoid receptors. | Metna-Laurent M et al. | β | 2015 | β |
| Selective blockade of the hydrolysis of the endocannabinoid 2-arachidonoylglycerol impairs learning and memory performance while producing antinociceptive activity in rodents. | Griebel G et al. | β | 2015 | β |
| The interplay between inflammatory cytokines and the endocannabinoid system in the regulation of synaptic transmission. | Rossi S et al. | β | 2015 | β |
| Anti-inflammatory effects of cannabinoid CB(2) receptor activation in endotoxin-induced uveitis. | Toguri JT et al. | β | 2014 | β |
| Dexamethasone alleviates motion sickness in rats in part by enhancing the endocannabinoid system. | Zheng Y et al. | β | 2014 | β |
| Perturbations of the endocannabinoid system in mantle cell lymphoma: correlations to clinical and pathological features. | Wasik AM et al. | β | 2014 | β |
| Physical activity and the endocannabinoid system: an overview. | Tantimonaco M et al. | β | 2014 | β |
| Prenatal exposure to the CB1 and CB2 cannabinoid receptor agonist WIN 55,212-2 alters migration of early-born glutamatergic neurons and GABAergic interneurons in the rat cerebral cortex. | Saez TM et al. | β | 2014 | β |
| The endocannabinoid/endovanilloid N-arachidonoyl dopamine (NADA) and synthetic cannabinoid WIN55,212-2 abate the inflammatory activation of human endothelial cells. | Wilhelmsen K et al. | β | 2014 | β |
| The endocannabinoid system: directing eating behavior and macronutrient metabolism. | Watkins BA et al. | β | 2014 | β |
| Toward modulation of the endocannabinoid system for treatment of gastrointestinal disease: FAAHster but not "higher". | Nasser Y et al. | β | 2014 | β |
| Active-site inhibitors modulate the dynamic properties of human monoacylglycerol lipase: a hydrogen exchange mass spectrometry study. | Karageorgos I et al. | β | 2013 | β |
| Cannabidiol as potential anticancer drug. | Massi P et al. | β | 2013 | β |
| Cannabinoids and hallucinogens for headache. | McGeeney BE | β | 2013 | β |
| Determination of the two major endocannabinoids in human plasma by ΞΌ-SPE followed by HPLC-MS/MS. | Sergi M et al. | β | 2013 | β |
| Endocannabinoid crosstalk between placenta and maternal fat in a baboon model (Papio spp.) of obesity. | Brocato B et al. | β | 2013 | β |
| Epigenetic mechanisms and endocannabinoid signalling. | D'Addario C et al. | β | 2013 | β |
| Temporal changes in N-acylethanolamine content and metabolism throughout the peri-adolescent period. | Lee TT et al. | β | 2013 | β |
| The endocannabinoid system: a revolving plate in neuro-immune interaction in health and disease. | Tanasescu R et al. | β | 2013 | β |
| The endocannabinoid system in advanced liver cirrhosis: pathophysiological implication and future perspectives. | Baldassarre M et al. | β | 2013 | β |
| Therapeutic modulation of cannabinoid lipid signaling: metabolic profiling of a novel antinociceptive cannabinoid-2 receptor agonist. | Wood JT et al. | β | 2013 | β |
| Transport of endocannabinoids across the plasma membrane and within the cell. | Fowler CJ | β | 2013 | β |
| Two to tango: GPCR oligomers and GPCR-TRP channel interactions in nociception. | Yekkirala AS | β | 2013 | β |
| Type-1 (CB1) cannabinoid receptor promotes neuronal differentiation and maturation of neural stem cells. | Compagnucci C et al. | β | 2013 | β |
| Virtual screening of CB(2) receptor agonists from bayesian network and high-throughput docking: structural insights into agonist-modulated GPCR features. | Renault N et al. | β | 2013 | β |
| 4-Oxo-1,4-dihydropyridines as selective CBβ cannabinoid receptor ligands. Part 2: discovery of new agonists endowed with protective effect against experimental colitis. | El Bakali J et al. | β | 2012 | β |
| ALSUntangled No. 16: cannabis. | ALSUntangled Group | β | 2012 | β |
| Altering endocannabinoid neurotransmission at critical developmental ages: impact on rodent emotionality and cognitive performance. | Trezza V et al. | β | 2012 | β |
| Effect of an acute consumption of a moderate amount of ethanol on plasma endocannabinoid levels in humans. | Feuerecker M et al. | β | 2012 | β |
| Effects of exercise stress on the endocannabinoid system in humans under field conditions. | Feuerecker M et al. | β | 2012 | β |
| Endocannabinoids in amygdala and nucleus accumbens mediate social play reward in adolescent rats. | Trezza V et al. | β | 2012 | β |
| Endocannabinoid system and proopiomelanocortin gene expression in peripartal bovine liver in response to prepartal plane of nutrition. | Khan MJ et al. | β | 2012 | β |
| Hallucinogens and cannabinoids for headache. | McGeeney BE | β | 2012 | β |
| Highly selective inhibitors of monoacylglycerol lipase bearing a reactive group that is bioisosteric with endocannabinoid substrates. | Chang JW et al. | β | 2012 | β |
| Mechanisms of endothelial dysfunction in obesity-associated hypertension. | Lobato NS et al. | β | 2012 | β |
| Monoacylglycerol lipase - a target for drug development? | Fowler CJ | β | 2012 | β |
| N-acyl taurines are anti-proliferative in prostate cancer cells. | Chatzakos V et al. | β | 2012 | β |
| Reversal of liver fibrosis by the antagonism of endocannabinoid CB1 receptor in a rat model of CCl(4)-induced advanced cirrhosis. | Giannone FA et al. | β | 2012 | β |
| The emerging role of acyl-CoA thioesterases and acyltransferases in regulating peroxisomal lipid metabolism. | Hunt MC et al. | β | 2012 | β |
| The thrifty lipids: endocannabinoids and the neural control of energy conservation. | DiPatrizio NV et al. | β | 2012 | β |
| Alternative targets within the endocannabinoid system for future treatment of gastrointestinal diseases. | Schicho R et al. | β | 2011 | β |
| Antagonist-elicited cannabis withdrawal in humans. | Gorelick DA et al. | β | 2011 | β |
| Cannabinoid exposure during zebra finch sensorimotor vocal learning persistently alters expression of endocannabinoid signaling elements and acute agonist responsiveness. | Soderstrom K et al. | β | 2011 | β |
| Cannabinoids modulate spontaneous synaptic activity in retinal ganglion cells. | Middleton TP et al. | β | 2011 | β |
| Changes in N-acylethanolamine Pathway Related Metabolites in a Rat Model of Cerebral Ischemia/Reperfusion. | Kilaru A et al. | β | 2011 | β |
| Endocannabinoid signal in the gut controls dietary fat intake. | DiPatrizio NV et al. | β | 2011 | β |
| Investigations of the human endocannabinoid system in two subcutaneous adipose tissue depots in lean subjects and in obese subjects before and after weight loss. | Bennetzen MF et al. | β | 2011 | β |
| Lipoxygenase-mediated oxidation of polyunsaturated N-acylethanolamines in Arabidopsis. | Kilaru A et al. | β | 2011 | β |
| Propofol enhances memory formation via an interaction with the endocannabinoid system. | Hauer D et al. | β | 2011 | β |
| Resorcinol-sn-glycerol derivatives: novel 2-arachidonoylglycerol mimetics endowed with high affinity and selectivity for cannabinoid type 1 receptor. | Brizzi A et al. | β | 2011 | β |
| SAR and LC/MS studies of Ξ²-lactamic inhibitors of human fatty acid amide hydrolase (hFAAH): evidence of a nonhydrolytic process. | Feledziak M et al. | β | 2011 | β |
| The atypical cannabinoid O-1602 protects against experimental colitis and inhibits neutrophil recruitment. | Schicho R et al. | β | 2011 | β |
| The major central endocannabinoid directly acts at GABA(A) receptors. | Sigel E et al. | β | 2011 | β |
| The secret "spice": an undetectable toxic cause of seizure. | de Havenon A et al. | β | 2011 | β |
| Basal and fasting/refeeding-regulated tissue levels of endogenous PPAR-alpha ligands in Zucker rats. | Izzo AA et al. | β | 2010 | β |
| Cannabinoid receptor 1 mediates palmitic acid-induced apoptosis via endoplasmic reticulum stress in human renal proximal tubular cells. | Lim JC et al. | β | 2010 | β |
| Cannabis and amyotrophic lateral sclerosis: hypothetical and practical applications, and a call for clinical trials. | Carter GT et al. | β | 2010 | β |
| Conversion of 4-cyanomethyl-pyrazole-3-carboxamides into CB1 antagonists with lowered propensity to pass the blood-brain-barrier. | Receveur JM et al. | β | 2010 | β |
| Dietary docosahexaenoic acid supplementation alters select physiological endocannabinoid-system metabolites in brain and plasma. | Wood JT et al. | β | 2010 | β |
| Effect of anaesthesia and cardiopulmonary bypass on blood endocannabinoid concentrations during cardiac surgery. | Weis F et al. | β | 2010 | β |
| Exploring SAR features in diverse library of 4-cyanomethyl-pyrazole-3-carboxamides suitable for further elaborations as CB1 antagonists. | Cooper M et al. | β | 2010 | β |
| Fatty acid amide lipid mediators in plants | Kim Sc et al. | β | 2010 | β |
| Lipid profiling reveals tissue-specific differences for ethanolamide lipids in mice lacking fatty acid amide hydrolase. | Kilaru A et al. | β | 2010 | β |
| Modulation of the endocannabinoid system: neuroprotection or neurotoxicity? | Fowler CJ et al. | β | 2010 | β |
| Motion sickness, stress and the endocannabinoid system. | ChoukΓ¨r A et al. | β | 2010 | β |
| Naphthalen-1-yl-(4-pentyloxynaphthalen-1-yl)methanone (SAB378), a peripherally restricted cannabinoid CB1/CB2 receptor agonist, inhibits gastrointestinal motility but has no effect on experimental colitis in mice. | Cluny NL et al. | β | 2010 | β |
| Rimonabant-induced apoptosis in leukemia cell lines: activation of caspase-dependent and -independent pathways. | Gallotta D et al. | β | 2010 | β |
| Substantially altered expression pattern of cannabinoid receptor 2 and activated endocannabinoid system in patients with severe heart failure. | Weis F et al. | β | 2010 | β |
| Targeting the cannabinoid pathway limits the development of fibrosis and autoimmunity in a mouse model of systemic sclerosis. | Servettaz A et al. | β | 2010 | β |
| The endocannabinoid system and its relevance for nutrition. | Maccarrone M et al. | β | 2010 | β |
| The endocannabinoid system in the inflammatory and neurodegenerative processes of multiple sclerosis and of amyotrophic lateral sclerosis. | Rossi S et al. | β | 2010 | β |
| Simultaneous quantitative analysis of N-acylethanolamides in clinical samples. | Ozalp A et al. | β | 2009 | β |
| Synthesis and biological evaluation of piperazinyl carbamates and ureas as fatty acid amide hydrolase (FAAH) and transient receptor potential (TRP) channel dual ligands. | Morera E et al. | β | 2009 | β |